Venture Capital

PulseAI: Seed Funding Secured To Advance AI-Driven ECG Diagnostics

By Amit Chowdhry ● Jan 12, 2026

PulseAI announced it has closed a seed funding round to expand deployment of its AI-enabled electrocardiogram (ECG) diagnostics platform and progress toward U.S. FDA 510(k) clearance, positioning the company to commercialize clinical decision-support tools for both primary care and acute care environments.

Inquis Medical: $75 Million Series C Raised To Expand AVENTUS Thrombectomy Commercial Rollout

By Amit Chowdhry ● Jan 12, 2026

Inquis Medical announced it closed a $75 million Series C financing to accelerate nationwide commercial expansion of its AVENTUS thrombectomy system and advance a next-generation product pipeline, as the company looks to scale adoption in venous thromboembolic disease (VTE).

Polar Light Technologies: €5+ Million Raised To Push Pyramidal MicroLEDs Toward First Product Launches

By Amit Chowdhry ● Jan 12, 2026

Polar Light Technologies AB, a Linköping, Sweden-based semiconductor company developing MicroLED display technology, announced it has closed a €5 million-plus funding round to support commercialization and the rollout of its first products. The round was led by J2L Holding AB, with participation from STOAF, Almi Invest and Butterfly Ventures. Polar Light said the financing extends its runway as it prepares initial product launches built on its pyramidal MicroLED platform.

Elevate Capital Invests $1.6 Million in 5 Oregon Startups Through State-Backed Venture Program

By Amit Chowdhry ● Jan 12, 2026

Elevate Capital announced it has deployed $1.6 million into five Oregon-based startups through the state’s Venture Direct program, a venture capital initiative supported by the federal State Small Business Credit Initiative (SSBCI). The firm said the investments are intended to expand access to early-stage capital for local founders and support long-term economic growth across Oregon.

Applied Brain Research Raises Seed Round To Scale On-Device Voice AI With TSP1 Edge Chip

By Amit Chowdhry ● Jan 12, 2026

Applied Brain Research (ABR) announced it has closed an oversubscribed seed funding round to accelerate development and commercialization of its TSP1 “state space accelerator” chip and accompanying software models for edge AI inference. The round was led by Two Small Fish Ventures, and the firm’s general partner Eva Lau will join ABR’s board.

Ventaris Surgical: $30 Million Series A Raised To Develop System For Complete Kidney Stone Treatment

By Amit Chowdhry ● Jan 12, 2026

Ventaris Surgical, a San Carlos, California-based medical device company, has closed a $30 million Series A financing round to advance a ureteroscopic platform designed to improve stone clearance during kidney stone procedures. The round was led by Longitude Capital, with new investor Vensana Capital also participating. Existing backers Atypical Ventures, Neotribe Ventures, and Boutique Venture Partners also joined the financing.

Neuramint: $5 Million Seed Round Raised To Build AI Agent Workflow Platform For Web3

By Amit Chowdhry ● Jan 12, 2026

Neuramint announced it has raised a $5 million seed round to develop an AI agent workflow platform designed to help developers build and manage autonomous Web3 workflows across decentralized finance, NFTs, and blockchain networks.

Synchrony Medical Lands $1 Million NJIEF Investment To Expand LibAirty Airway Clearance System Across the U.S.

By Amit Chowdhry ● Jan 12, 2026

Synchrony Medical announced it has secured a $1 million investment from the New Jersey Innovation Evergreen Fund (NJIEF), with the capital matching an investment from Edge Medical Ventures. The company said the funding will be used to accelerate U.S. commercial operations, support ongoing clinical research and product development, and broaden patient access to its LibAirty at-home airway clearance system through respiratory clinics, hospitals, and homecare networks nationwide.

Peachtree Posts Record $3 Billion In 2025 Credit Deployments As Private Lending Platform Scales

By Amit Chowdhry ● Jan 12, 2026

Peachtree Group announced it deployed $3 billion across credit transactions in 2025, an 86.8% increase from 2024 as the Atlanta-based commercial real estate investment platform continued to expand beyond its hospitality roots and scale its private lending business.

Accelsius: $65 Million Series B Raised To Scale Two-Phase Liquid Cooling for AI Infrastructure

By Amit Chowdhry ● Jan 12, 2026

Accelsius closed a $65 million Series B financing led by Johnson Controls, with Legrand joining as a strategic investor, as the company ramps production and expands deployment of its two-phase, direct-to-chip liquid cooling technology for AI and high-performance computing environments.

X-Caliber: $182.2 Million Rural PACE-X Financing Closed For Marcella Landing at Deer Valley In Park City

By Amit Chowdhry ● Jan 12, 2026

X-Caliber Capital Holdings announced it has closed a $182.2 million Rural PACE-X financing package to fund the ground-up construction of Marcella Landing at Deer Valley, an ultra-luxury ski community being developed by Reef Capital Partners in Park City, Utah.

OutSee: £2.5 Million Seed Round Completed And Partnership With o2h Discovery

By Amit Chowdhry ● Jan 12, 2026

OutSee, an AI-enabled genomics and drug discovery company, has closed a £2.5 million seed funding round and signed a strategic agreement with o2h discovery to begin a collaborative drug discovery programme around OutSee’s lead drug target candidate.

Cast AI Surpasses $1 Billion Valuation Following Pacific Alliance Ventures Strategic Investment

By Amit Chowdhry ● Jan 12, 2026

Cast AI announced it has crossed a $1 billion valuation following a strategic investment from Pacific Alliance Ventures (PAV), the U.S.-based corporate venture arm of Shinsegae Group, as the company launched OMNI Compute, a unified compute marketplace designed to help enterprises access and operate GPU capacity across clouds and regions without making code changes.

Tench And Simone Coxe Donate $100 Million To Launch UT Austin Academic Medical Center

By Amit Chowdhry ● Jan 12, 2026

The University of Texas at Austin said it is moving forward with its planned academic medical center after receiving a $100 million gift from Austin residents Tench and Simone Coxe, one of the largest donations in the university’s history.

Allos: $5 Million Raised To Apply Causal AI Across Complex Drug Reformulation

By Amit Chowdhry ● Jan 12, 2026

Allos AI has raised $5 million in seed financing to commercialize what it calls the industry’s first “glass-box” Causal AI platform for reformulating complex generic drugs, as developers and manufacturers look for lower-risk ways to improve how established medicines are delivered and tolerated over long-term use.

Aspen Power Secures $200 Million Strategic Capital Commitment From Deutsche Bank

By Amit Chowdhry ● Jan 12, 2026

Aspen Power announced it has closed a $200 million capital raise from Deutsche Bank, bolstering the Carlyle-backed distributed generation platform’s financial capacity as it scales development of solar and storage projects across the U.S.

Nassau Global Credit: $400 Million In Commitments For New Credit Opportunities Strategy

By Amit Chowdhry ● Jan 12, 2026

Nassau Global Credit (NGC) announced the launch of a new Credit Opportunities strategy backed by capital commitments of up to $400 million from seed investors, expanding the firm’s credit-investing toolkit across the U.S. and Europe.

VelaFi: $20 Million Series B Raised To Expand Global Stablecoin Infrastructure

By Amit Chowdhry ● Jan 12, 2026

VelaFi, a stablecoin-powered financial infrastructure platform under Galactic Holdings, announced it has raised $20 million in a Series B financing to expand its regulated payments and settlement capabilities across Latin America, the U.S., and Asia.

Vibrant Therapeutics: $61 Million Closed And Han Lee Named As Co-CEO

By Amit Chowdhry ● Jan 12, 2026

Vibrant Therapeutics, a clinical-stage biotech developing “logic-gated” therapeutics designed to activate selectively in diseased tissue, announced it has raised $61 million in new financing and appointed Han Lee, Ph.D. as co-chief executive officer as the company prepares to broaden global development of its lead solid tumor program. The round brought in new investors, Pfizer Ventures and Apricot Capital, and included participation from Bayland Capital, HSG, Northern Light Venture Capital, and First Principle Venture Limited, according to the company. With the latest proceeds, Vibrant said its total capital raised now stands at $100 million.

Mirador Therapeutics: $250 Million Series B Raised And Multi-Asset Immuno-Fibrotic Pipeline Advanced

By Amit Chowdhry ● Jan 12, 2026

Mirador Therapeutics announced it is advancing multiple clinical-stage programs across Crohn’s disease, ulcerative colitis, rheumatoid arthritis, and idiopathic pulmonary fibrosis, with more than 10 clinical readouts expected by the end of 2027.

VieCure: $43 Million Raised To Expand AI-Powered Precision Cancer Care In Community Practices

By Amit Chowdhry ● Jan 12, 2026

VieCure announced it has raised $43 million to accelerate the rollout of its software platform designed to help community oncology clinics deliver precision-medicine care with greater speed and consistency.

Cytotheryx Lands Lead For $60 Million Series A And Adds Debt Financing To Expand Facilities

By Amit Chowdhry ● Jan 12, 2026

Cytotheryx, a preclinical cell therapy company developing cell-based treatments for liver disease, said it has secured a lead term sheet for a $60 million Series A round and lined up additional debt financing aimed at expanding its manufacturing and operational footprint.

DaVinci Commerce Raises Strategic Financing, Rebrands From Jivox To Expand Agentic Commerce Marketing Platform

By Amit Chowdhry ● Jan 12, 2026

DaVinci Commerce, formerly known as Jivox, announced it raised a strategic financing round to accelerate growth of its AI-native platform for “agentic commerce marketing,” a category it says blends automated commerce creative optimization with rapid activation across retail and commerce media networks.

Trybe: $30 Million Series A Raised To Expand Spa And Leisure Management Platform

By Amit Chowdhry ● Jan 12, 2026

Trybe, a provider of software for spas, bathhouses, resorts, hotels, and other leisure operators, has raised a $30 million Series A investment from Five Elms Capital as it looks to scale internationally and deepen product capabilities across payments, bookings, and operations.

Harmattan AI: $200 Million Series B Raised And Strategic Partnership With Dassault Aviation

By Amit Chowdhry ● Jan 12, 2026

Dassault Aviation and Harmattan AI announced they have formed a strategic partnership aimed at accelerating the integration of controlled autonomy and artificial intelligence into combat aviation systems, with Dassault leading a $200 million Series B financing for the defense technology company.

Arkin Capital Closes $100 Million Bio Ventures III Fund For Early-Stage Biotech Investing

By Amit Chowdhry ● Jan 12, 2026

Arkin Capital announced it has closed Arkin Bio Ventures III, a $100 million fund that will back advanced pre-clinical and early clinical-stage biotechnology companies developing therapies for high unmet medical needs.

Terra Industries Raises $11.75 Million To Scale Autonomous Security Systems For Africa’s Critical Infrastructure

By Amit Chowdhry ● Jan 12, 2026

Terra Industries, a defense technology company developing autonomous security systems to protect critical infrastructure across Africa, has emerged from stealth with an $11.75 million funding round led by U.S. venture firm 8VC.

QXO Upsizes Convertible Preferred Equity Commitment to $3 Billion

By Amit Chowdhry ● Jan 12, 2026

QXO announced it has expanded a previously announced convertible preferred equity financing to $3 billion, increasing the commitment by $1.8 billion, as it seeks additional capacity to fund future acquisitions.

Avenue Biosciences: $5.7 Million Seed Extension Raised To Scale Secretory Pathway Platform For Therapeutic Protein Manufacturing

By Amit Chowdhry ● Jan 12, 2026

Avenue Biosciences, a Palo Alto-based protein engineering technology company, has raised $5.7 million in seed extension funding to scale a high-throughput platform designed to measure and modulate the protein secretory pathway, a core cellular process responsible for folding, modifying, and secreting therapeutic proteins.

Apheon: €1.25 Billion Closed For Sixth Flagship Midcap Buyout Fund

By Amit Chowdhry ● Jan 12, 2026

Apheon Management announced it has closed its sixth flagship mid-market vehicle, Apheon MidCap Buyout VI SCSp, at the €1.25 billion hard cap, with an additional €50 million commitment from the firm’s team and related families, bringing total fund size to €1.3 billion.